@interrobangbros agree. But trying to learn how to differentiate between mgmt who can execute and those who are aspiring but can’t implement…sold out of $BFLY around the $8-10, down from a high of $20 something and cost basis of $15-17! Will review $TMDX and $OM for my portfolio the next few months to see if it’s worth entering into. To be honest 2022 is a cleanup year from all the mistakes that were “floating nicely” in the rising tides!
@passiveinvestor My BFLY position is quite small so I’m holding and hoping. I’d recommend OM over TMDX as OM is a big further along but TMDX’s tech could be more revolutionary according to my wife who is a doctor and surgical resident. Let me know if you have any other medtech positions that I didn’t mention. Always on the lookout for now opportunities!